Navigation Links
Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results
Date:5/5/2009

CALGARY, May 5 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY) ("Oncolytics" or the "Company") today announced its financial results for the three-month period ended March 31, 2009.

"The first quarter of 2009 was highlighted by the announcement of very positive results in several of our combination REOLYSIN(R) clinical trials," said Dr. Brad Thompson, President and CEO of Oncolytics. "We continue to report clinical benefit in the majority of patients treated with REOLYSIN in combination with chemotherapy or radiation, paving the way for our pivotal program to begin this year."

    Selected First Quarter Highlights:

    -  Announced positive interim results from a U.K. Phase I/II combination
       REOLYSIN and paclitaxel/carboplatin trial for patients with advanced
       head and neck cancers. Of 12 evaluable patients, five patients had
       partial responses (PR) and four patients had stable disease (SD), for
       a clinical benefit rate (complete response + partial response + stable
       disease) of 75%;

    -  Announced positive results from a U.K. combination REOLYSIN and
       docetaxel trial for patients with a variety of advanced cancers.
       Fifteen of the 17 evaluable patients experienced SD or better,
       including two PR, three minor responses and 10 SD, giving a clinical
       benefit rate of 88%;

    -  Completed enrolment in a U.K. combination REOLYSIN and gemcitabine
       clinical trial. Of the ten patients evaluable for response, two
       patients (breast and nasopharyngeal) had PRs and five patients had SD,
       for a clinical benefit rate of 70%;

    -  Started patient enrolment in a U.S. Phase 2 Combination REOLYSIN and
       paclitaxel/carboplatin clinical trial for patients with non-small cell
       lung cancer with K-RAS or EGFR-activated tumo
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
2. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009
3. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
4. Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
5. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
6. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
7. Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
8. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
9. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
10. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America
11. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , ... September 02, 2015 , ... ... and life science research, today unveiled Genedata Screener ® version 13.0 at ... in-vitro screening brings to market a rich set of new capabilities. Screener now ...
(Date:9/1/2015)... Blythewood, South Carolina (PRWEB) , ... September 02, 2015 , ... ... solutions, has released new features to its eCommerce site Spirax Sarco Anytime. This ... , Why wait to place your next order? Log on to Spirax ...
(Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
(Date:9/1/2015)... , ... September 01, 2015 ... ... launch of the new ImageXpress® Micro Confocal High-Content Imaging System. This transformative ... assays that use 3D cellular models such as spheroids, tissues, and organisms. ...
Breaking Biology Technology:New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4Spirax Sarco Announces New Features to Anytime Platform 2ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 3
... Joseph F. Finn, Jr.,C.P.A. ("Finn"), Assignee ... for,the benefit of creditors, announced today that ... sold at a sealed bid auction on ... hydrophobic thermoplastic,polymers, Spheromers(TM), have superior conventional hydrophilic,bioadhesive ...
... InNexus,Biotechnology Inc., (TSX: IXS.V, OTC Bulletin Board: IXSBF, ... next,generation of monoclonal antibodies based on its Dynamic ... Board of Directors., Mr. Warden was a ... his 23 years of practice, he has represented ...
... Calif., Sept. 9 Energy crop company,Ceres, Inc. ... and high-biomass sorghum hybrids with Range Fuels, Inc. ... the site of Range Fuels,commercial-scale cellulosic ethanol plant, ... southeast of Atlanta., While wood residues will ...
Cached Biology Technology:Spherics, Inc. Announces Sale of Novel Proprietary Bioadhesive Polymers and Oral Drug Delivery System 2InNexus Biotechnology Strengthens Patent Team With New Leadership 2Ceres Trials Energy Crops at Georgia Biofuel Facility 2Ceres Trials Energy Crops at Georgia Biofuel Facility 3
(Date:9/1/2015)... Sept. 1, 2015  Automation and pre-processing are ... passenger screening. This is the first step toward ... will become unintrusive. An assortment of portal scanners, ... background investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( ...
(Date:8/26/2015)... The report "Multi-Factor Authentication (MFA) Market ... (Travel & Immigration, Government, Banking, Defense, Commercial Security, Consumer ... published by MarketsandMarkets, Multi-Factor Authentication Market is expected to ... CAGR of 17.7% between 2015 and 2020. ... spread through 169 P ages and ...
(Date:8/20/2015)... 20, 2015 The wearable technology market ... active and healthy. However, wearable technology has the ... to help improve diagnostic capabilities and therapeutic outcomes. ... Wearable Technologies Conference 2015 , where ... wearables in healthcare.    "Over the ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... Queen,s University biologists are part of an international ... in a remote Arctic lake provides compelling evidence of ... "Our findings show that the last several ... years," says Neal Michelutti, a research scientist at the ...
... that biological and chemical changes occurring at a remote Arctic ... are the result of human-caused climate change, according to a ... While environmental changes at the lake over the ... natural causes of climate change -- like periodic, well-understood wobbles ...
... key to new ways to fight cancer and other ... in regulating circadian rhythm, says Liheng Shi, a researcher ... rhythm is the roughly 24-hour cycle of physiological activities ... and colleagues have had their research, currently focusing on ...
Cached Biology News:Queen's scientists on international team discover 'ecologically unique' changes in Arctic lake 2Arctic lake sediments show warming, unique ecological changes in recent decades 2Arctic lake sediments show warming, unique ecological changes in recent decades 3Texas A&M researchers find new mechanism for circadian rhythm 2
Ps-Aeruginosa (IgA) -Ab EIA Sample Size: 100 l...
... bench time to just 15 minutes! The ... that can be drawn between this exciting new ... instant foods. Instant meals consumed by astronauts, ... and are reconstituted by adding water. The ...
Automated -80° C sample library for microplates and cryotube racks in SBS format; for integration into automated processes....
Candida (IgA) -Ab EIA Sample Size: 5 l...
Biology Products: